A reduced size of the ovarian follicle pool is associated with an increased risk of a trisomic pregnancy in IVF-treated women

Human Reproduction

Volumn 25, Issue 2, 2010, Pages 552-558

  Haadsma, M L ^a   Mooij, T M ^b   Groen, H ^a   Burger, C W ^c   Lambalk, C B ^d   Broekmans, F J M ^e   Van Leeuwen, F E ^b   Bouman, K ^a   Hoek, A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

In vitro fertilization; Ovarian reserve; Poor response; Trisomic pregnancy; Trisomy

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONCEPTION; CONTROLLED STUDY; DATA BASE; FEMALE; FERTILIZATION IN VITRO; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MENOPAUSE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PREGNANCY; QUESTIONNAIRE; SELF REPORT; TRISOMY;

EID: 74549186978     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep404     Document Type: Article

References (41)

1. Baird DT, Collins J, Egozcue J, Evers LH, Gianaroli L, Leridon H, Sunde A, Templeton A, Van SA, Cohen J et al. Fertility and ageing. Hum Reprod Update 2005;11:261-276.
2. Bartmann AK, Araujo FM, Iannetta O, Paneto JC, Martelli L, Ramos ES. Down syndrome and precocious menopause. J Assist Reprod Genet 2005;22:129-131.
3. Broekmans FJ, Scheffer GJ, Bancsi LF, Dorland M, Blankenstein MA, Te Velde ER. Ovarian reserve tests in infertility practice and normal fertile women. Maturitas 1998;30:205-214.
4. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
5. Brook JD, Gosden RG, Chandley AC. Maternal ageing and aneuploid embryos-evidence from the mouse that biological and not chronological age is the important influence. Hum Genet 1984; 66:41-45.
6. De Boer EJ, Den Tonkelaar I, Te Velde ER, Burger CW, Klip H, Van Leeuwen FE. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002;77:978-985.
7. De Boer EJ, Den Tonkelaar I, Te Velde ER, Burger CW, Van Leeuwen FE. Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 2003; 18:1544-1552.
8. De Jong-van den Berg LT, Faber A, Van den Berg PB. HRT use in 2001 and 2004 in The Netherlands-a world of difference. Maturitas 2006; 54:193-197.
9. Dursun P, Gultekin M, Yuce K, Ayhan A. What is the underlying cause of aneuploidy associated with increasing maternal age? Is it associated with elevated levels of gonadotropins? Medical Hypotheses 2005; 66:143-147.
10. Eichenlaub-Ritter U. Genetics of oocyte ageing. Maturitas 1998; 30:143-169.
11. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992;7:1342-1346.
12. Freeman SB, Yang Q, Allran K, Taft LF, Sherman SL. Women with a reduced ovarian complement may have an increased risk for a child with Down syndrome. Am J Hum Genet 2000;66:1680-1683.
13. Freeman SB, Allen EG, Oxford-Wright CL, Tinker SW, Druschel C, Hobbs CA et al. The National Down Syndrome Project: design and implementation. Public Health Rep 2007;122:62-72.
14. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive ageing: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod 2008;23:699-708.
15. Hassold T, Chiu D. Maternal age-specific rates of numerical chromosome abnormalities with special reference to trisomy. Hum Genet 1985; 70:11-17.
16. Hassold T, Abruzzo M, Adkins K, Griffin D, Merrill M, Millie E, Saker D, Shen J, Zaragoza M. Human aneuploidy: incidence, origin, and etiology. Environ Mol Mutagen 1996;28:167-175. (Pubitemid 26380273)
17. Hassold T, Hunt P. To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet 2001;2:280-291.
18. Henderson SA, Edwards RG. Chiasma frequency and maternal age in mammals. Nature 1968;218:22-28.
19. Kline J, Kinney A, Levin B, Warburton D. Trisomic pregnancy and earlier age at menopause. Am J Hum Genet 2000;67:395-404.
20. Kline J, Kinney A, Reuss ML, Kelly A, Levin B, Ferin M, Warburton D. Trisomic pregnancy and the oocyte pool. Hum Reprod 2004; 19:1633-1643.
21. Klip H, Van Leeuwen FE, Schats R, Burger CW. Risk of benign gynaecological diseases and hormonal disorders according to responsiveness to ovarian stimulation in IVF: a follow-up study of 8714 women. Hum Reprod 2003;18:1951-1958.
22. Lawson R, El-Toukhy T, Kassab A, Taylor A, Braude P, Parsons J, Seed P. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. Hum Reprod 2003;18:527-533.
23. Loutradis D, Drakakis P, Milingos S, Stefanidis K, Michalas S. Alternative approaches in the management of poor response in controlled ovarian hyperstimulation (COH). Ann N Y Acad Sci 2003;997:112-119.
24. McTavish KJ, Jimenez M, Walters KA, Spaliviero J, Groome NP, Themmen AP, Visser JA, Handelsman DJ, Allan CM. Rising follicle-stimulating hormone levels with age accelerate female reproductive failure. Endocrinology 2007;148:4432-4439.
25. Melica F, Chiodi S, Cristoforoni PM, Ravera GB. Reductive surgery and ovarian function in the human-can reductive ovarian surgery in reproductive age negatively influence fertility and age at onset of menopause? Int J Fertil Menopausal Stud 1995;40:79-85.
26. Nasseri A, Mukherjee T, Grifo JA, Noyes N, Krey L, Copperman AB. Elevated day 3 serum follicle stimulating hormone and/or estradiol may predict fetal aneuploidy. Fertil Steril 1999;71:715-718.
27. Rookus MA, Van Leeuwen FE. Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group. Lancet 1994; 344:844-851.
28. Rothman KJ, Greenland S. Introduction to stratified analysis. In: Rothman KJ, Greenland S (eds.). Modern Epidemiology. Philadelphia, USA: Lippincott-Raven, 1998, 256-258.
29. Saldeen P, Kallen K, Sundstrom P. The probability of successful IVF outcome after poor ovarian response. Acta Obstet Gynecol Scand 2007;86:457-461.
30. Seifer DB, MacLaughlin DT, Cuckle HS. Serum Mullerian-inhibiting substance in Down's syndrome pregnancies. Hum Reprod 2007; 22:1017-1020.
31. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, McTavish AR. Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev 2007;CD004379.
32. Te Velde ER, Dorland M, Broekmans FJ. Age at menopause as a marker of reproductive ageing. Maturitas 1998;30:119-125.
33. Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141-154.
34. Ubaldi FM, Rienzi L, Ferrero S, Baroni E, Sapienza F, Cobellis L, Greco E. Management of poor responders in IVF. Reprod Biomed Online 2005; 10:235-246.
35. Van Montfrans JM, Dorland M, Oosterhuis GJ, Van Vugt JM, Rekers-Mombarg LT, Lambalk CB. Increased concentrations of follicle-stimulating hormone in mothers of children with Down's syndrome. Lancet 1999;353:1853-1854.
36. Van Montfrans JM, Van Hooff MH, Martens F, Lambalk CB. Basal FSH, estradiol and inhibin B concentrations in women with a previous Down's syndrome affected pregnancy. Hum Reprod 2002;17:44-47.
37. Van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, De Jong FH, Fauser BJ, Themmen AP, Te Velde ER. Serum antiMullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005;83:979-987.
38. Visser JA, De Jong FH, Laven JS, Themmen AP. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 2006;131:1-9.
39. Warburton D. The effect of maternal age on the frequency of trisomy: change in meiosis or in utero selection? Prog Clin Biol Res 1989; 311:165-181.
40. Warburton D. Biological aging and the etiology of aneuploidy. Cytogenet Genome Res 2005;111:266-272.
41. Zheng CJ, Byers B. Oocyte selection: a new model for the maternal-age dependence of Down syndrome. Hum Genet 1992;90:1-6.